Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Cancer or Tumor Profiling Market, by Technology, 2016-2026 (USD Billion)
1.3.2. Cancer or Tumor Profiling Market, by Cancer Type, 2016-2026 (USD Billion)
1.3.3. Cancer or Tumor Profiling Market, by Application, 2016-2026 (USD Billion)
1.3.4. Cancer or Tumor Profiling Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Cancer or Tumor Profiling Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Cancer or Tumor Profiling Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Cancer or Tumor Profiling Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer/Tumour Profiling Market, By Technology
5.1. Market Snapshot
5.1. Market Performance - Potential Model
5.2. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
5.2.1. Immunoassays
5.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.2. Hybridization
5.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.3. Next Generation Sequencing
5.2.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.4. Mass Spectrometry
5.2.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.5. Other Technologies
5.2.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Global Cancer/Tumour Profiling Market, By Cancer Type
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
6.3.1. Lung Cancer
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Breast Cancer
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3. Colorectal Cancer
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4. Prostate Cancer
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.5. Melanoma Cancer
6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.6. Other Cancers
6.3.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Global Cancer/Tumour Profiling Market, By Application
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
7.3.1. Clinical Application
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Research Application
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Global Cancer/Tumour Profiling Market, by Regional Analysis
8.1. Cancer/Tumour Profiling Market, Regional Market Snapshot (2016-2026)
8.2. North America Cancer/Tumour Profiling Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3. Europe Cancer/Tumour Profiling Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4. Asia Cancer/Tumour Profiling Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5. Latin America Cancer/Tumour Profiling Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Illumina, Inc.
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Qiagen N.V.
9.3.3. Neogenomics Laboratories, Inc.
9.3.4. HTG Molecular Diagnostics, Inc.
9.3.5. Genomic Health Inc.
9.3.6. Caris Life Sciences
9.3.7. Helomics Corporation
9.3.8. Nanostring Technologies, Inc.
9.3.9. Oxford Gene Technology
9.3.10. Ribomed Biotechnologies, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption